Bayobay, Khalil Kent .
HRN: 21-83-29 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2022
AMPICILLIN 500MG (VIAL)
12/14/2022
12/20/2022
IVT
150 Mg
Q6
Acute Tonsillopharyngitis Urti
Waiting Final Action
Indication: Prophylaxis Type of Infection: URTIEye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes